AbCellera Biologics Inc. (ABCL) Financial Ratios & Valuation Metrics Analysis - P/E, ROE, Debt Ratios & Profitability - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    AbCellera Biologics Inc.

    NASDAQ: ABCL · Real-Time Price · USD
    5.90
    -0.08 (-1.34%)
    At close: Oct 03, 2025, 3:59 PM
    6.23
    5.59%
    Pre-market: Oct 06, 2025, 06:31 AM EDT

    AbCellera Biologics Ratios and Metrics

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    PE Ratio
    		 -5.3 -11.28 18.22 25.70
    PEG Ratio
    		 -0.68 0.06 n/a 0.94
    PS Ratio
    		 29.91 43.42 5.95 10.51
    PB Ratio
    		 0.82 1.43 2.34 3.84
    P/FCF Ratio
    		 -4.61 -13.6 14.11 21.19
    P/OCF Ratio
    		 -7.94 -37.63 10.41 16.12
    OCF/S Ratio
    		 -3.76 -1.15 0.57 0.65
    Debt / Equity Ratio
    		 0.06 0.07 0.07 0.04
    Quick Ratio
    		 9.81 7.32 8.65 7.69
    Current Ratio
    		 9.81 7.33 8.67 7.70
    Asset Turnover
    		 0.02 0.03 0.32 0.28
    Interest Coverage
    		 n/a n/a 53.53 39.12
    Return on Equity
    		 -0.15 -0.13 0.13 0.15
    Return on Assets
    		 -0.12 -0.1 0.10 0.12
    Return on Invested Capital
    		 -0.2 -0.15 0.10 0.12
    Dividend Yield
    		 n/a n/a n/a n/a
    Payout Ratio
    		 n/a n/a n/a n/a
    Gross Profit Margin
    		 -2.36 0.19 0.86 0.88
    Net Profit Margin
    		 -5.65 -3.85 0.33 0.41
    Pretax Profit Margin
    		 -6.95 -4.58 0.49 0.58
    Operating Profit Margin
    		 -10.92 -6.24 0.45 0.54
    FCF Margin
    		 -6.48 -3.19 0.42 0.50
    EBITDA Margin
    		 -7.08 -5.05 0.56 0.64

    Add to Watchlist